View Older Stories

Jun 3, 2026 07:00AM Syndax Pharmaceuticals (SNDX) Reiterated at Buy by Stifel

Jun 3, 2026 06:52AM H.C. Wainwright Reiterates Buy Rating on Syndax Pharmaceuticals (SNDX)

Jun 2, 2026 04:01PM SYNDAX highlights revumenib post-transplant data at ASCO 2026

May 21, 2026 05:01PM Syndax gets four Revuforj abstracts accepted for ASCO 2026

May 4, 2026 07:24AM Syndax Pharmaceuticals (SNDX) PT Raised to $46 at Stifel on Revuforj Confidence

May 1, 2026 04:10PM Syndax Pharmaceuticals (SNDX) PT Raised to $46 at Stifel

May 1, 2026 03:12PM Syndax Pharmaceuticals (SNDX) PT Lowered to $37 at Jefferies

May 1, 2026 04:38AM Syndax Pharmaceuticals (SNDX) PT Raised to $29 at BofA Securities

Apr 30, 2026 04:28PM Syndax Pharmaceuticals (SNDX) Tops Q1 EPS by 14c

Apr 23, 2026 02:16PM Syndax Pharmaceuticals (SNDX) spreader of 1500 contracts of June 24 calls, June 30 calls and June 18 puts

Mar 30, 2026 08:57AM Syndax Pharmaceuticals (SNDX) PT Lowered to $43 at Mizuho

Mar 27, 2026 04:14PM Syndax Pharmaceuticals (SNDX) PT Lowered to $40 at Jefferies

Mar 16, 2026 02:04PM Syndax Pharmaceuticals (SNDX) spreader of April 22 puts, April 25 calls and April 28 calls

Feb 27, 2026 12:03PM Syndax Pharmaceuticals (SNDX) PT Raised to $45 at Stifel

Feb 26, 2026 04:40PM Syndax Pharmaceuticals (SNDX) Misses Q4 EPS by 19c

Feb 4, 2026 06:51AM B.Riley Reiterates Buy Rating on Syndax Pharmaceuticals (SNDX)

Jan 12, 2026 07:08AM Syndax reports $277 million combined revenue for cancer drugs in 2025

Dec 9, 2025 06:55AM H.C. Wainwright Reiterates Buy Rating on Syndax Pharmaceuticals (SNDX)

Dec 9, 2025 04:34AM TD Cowen on Syndax Pharmaceuticals (SNDX): 'We found the updates at ASH generally encouraging'

Dec 8, 2025 06:50AM Syndax presents real-world data for menin inhibitor at ASH conference

Nov 4, 2025 09:31AM Stifel Reiterates Buy Rating on Syndax Pharmaceuticals (SNDX)

Nov 4, 2025 04:21AM Syndax Pharmaceuticals (SNDX) PT Raised to $27 at Goldman Sachs

Nov 3, 2025 04:05PM Syndax Pharmaceuticals (SNDX) Tops Q3 EPS by 3c

Nov 3, 2025 09:09AM Syndax receives 23 abstracts accepted for ASH 2025 meeting

Oct 27, 2025 07:48AM Syndax Pharmaceuticals' (SNDX) Revuforj Expansion a Long-term Growth Lever- Stifel

Oct 24, 2025 01:08PM FDA approves Syndax Pharmaceuticals' (SNDX) revumenib for myeloid leukemia

Oct 24, 2025 12:57PM Syndax Pharmaceuticals (SNDX) halted, news pending

Oct 16, 2025 06:39AM H.C. Wainwright Assumes Syndax Pharmaceuticals (SNDX) at Buy

Oct 16, 2025 06:16AM BofA Shuffles Endeavor List Names

Sep 19, 2025 07:00AM NCCN adds Syndax's Revuforj to leukemia treatment guidelines

Sep 10, 2025 01:59AM Stifel Resumes Syndax Pharmaceuticals (SNDX) at Buy

Sep 4, 2025 05:41AM Guggenheim Starts Syndax Pharmaceuticals (SNDX) at Buy

Aug 6, 2025 08:01AM B.Riley Assumes Syndax Pharmaceuticals (SNDX) at Buy

Aug 5, 2025 11:15AM Syndax Pharmaceuticals (SNDX) PT Raised to $51 at Citi, Opens 90d Catalyst Watch

Aug 5, 2025 06:26AM Syndax Pharmaceuticals (SNDX) PT Raised to $56 at BTIG

Aug 5, 2025 05:12AM Syndax Pharmaceuticals (SNDX) PT Raised to $20 at Goldman Sachs

Aug 4, 2025 04:55PM Syndax Pharmaceuticals (SNDX) Tops Q2 EPS by 18c

Jul 21, 2025 03:36PM Syndax Pharmaceuticals (SNDX) 4300 contracts of January 12.5 calls trade

Jul 21, 2025 10:58AM Increasing unusual call option volume: OPEN IVZ VERI ROIV URNM CX ABAT UAA SNDX

Jul 15, 2025 06:21AM Syndax Pharmaceuticals (SNDX) PT Lowered to $35 at UBS

Jul 10, 2025 02:25AM Goldman Sachs Starts Syndax Pharmaceuticals (SNDX) at Buy

Jun 24, 2025 04:02PM Syndax Pharmaceuticals (SNDX) announces FDA Priority Review of sNDA for Revuforj

Jun 12, 2025 12:03PM Syndax Pharmaceuticals (SNDX) announces data from BEAT AML trial evaluating revumenib

Jun 12, 2025 07:00AM Syndax Pharmaceuticals (SNDX) Presents New Revuforj Data in Relapsed/Refractory mNPM1 and NUP98r Acute Leukemia from AUGMENT-101 Trial

May 25, 2025 03:00PM Biotech stocks Q1 earnings review

May 6, 2025 07:09AM Syndax Pharmaceuticals (SNDX) PT Raised to $17 at Scotiabank

May 6, 2025 05:40AM Syndax Pharmaceuticals (SNDX) PT Raised to $26 at BofA Securities

May 5, 2025 04:29PM Syndax Pharmaceuticals (SNDX) Tops Q1 EPS by 26c

Mar 10, 2025 04:42AM Increasing unusual option volume: PEG CYH PRGO SNDX VSCO XLI AMPL

Mar 4, 2025 06:42AM H.C. Wainwright Reiterates Buy Rating on Syndax Pharmaceuticals (SNDX)

View Older Stories